Savient Pharmaceuticals (SVNTQ) News Today → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free SVNTQ Stock Alerts Add Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBuy Rating Affirmed for Aquestive Therapeutics on Strong Phase 3 Results for Anaphylm™ with Raised Price Targetmarkets.businessinsider.com - March 18 at 12:44 PMQuoin Pharmaceuticals Prices Offering Of Approx. 4.1 Mln Shares At $1.6/Share; Stock Tanksnasdaq.com - March 5 at 1:40 PMCrude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Highermsn.com - March 4 at 8:36 PMCorvus Pharmaceuticals Presents Soquelitinib Preclinical Data at the Keystone Symposia on Systemic Autoimmune and Autoinflammatory Diseasesmarkets.businessinsider.com - February 12 at 1:19 PMIndia's Torrent Pharma posts higher Q3 profit on strong domestic demandreuters.com - February 2 at 10:47 AMDevonian Seeks Shareholders Approval for Share Consolidationbusinesswire.com - January 19 at 7:37 PM4 Pharma Stocks to Buy, According to an Analyst. Novo Nordisk Isn’t One.msn.com - January 16 at 9:03 AMSail Biomedicines Appoints Tech and Pharma Industry Veteran Frank D'Amelio to Its Boardtmcnet.com - January 4 at 2:39 PMThe Analyst Verdict: Rhythm Pharmaceuticals In The Eyes Of 7 Expertsbenzinga.com - January 4 at 2:39 PMCorvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trialtmcnet.com - December 9 at 3:06 PMAbbVie Makes Another Big Pharma Acquisition. How It’s Putting Its Cash to Work.msn.com - December 7 at 9:23 AMFosun Pharma USA Announces Abstract to be Presented at IASLC 2023 North America Conference on Lung Cancer (NACLC)benzinga.com - November 28 at 3:37 PMSavient Pharmaceuticals Inc (SVNT)investing.com - October 22 at 10:13 PMPharma Logistics Awarded Department of Defense Contract for Pharmaceutical Reverse Distribution Servicesbusinesswire.com - October 3 at 6:02 PMDisposition of Common Shares of Small Pharma Inc.benzinga.com - October 2 at 8:17 PMLife Pharma inks distribution pact with pharmaceutical major PharmEvo of Pakistanmsn.com - September 30 at 8:02 PMAnnexin announces success in the company's cancer initiativebenzinga.com - September 29 at 8:44 AMAvalyn Pharma's CEO Leads Workshop on Clinical Strategy at IPF Summittechnews.tmcnet.com - September 18 at 3:31 PMScinai Immunotherapeutics Shares Fall Premarket After Stock Offering >SCNImarketwatch.com - September 16 at 9:52 AMUSFDA issues warning letter to Intas Pharma for Sanand plantmsn.com - August 6 at 8:35 AMTerns Pharmaceuticals (TERN) Receives a Buy from Mizuho Securitiesmarkets.businessinsider.com - August 3 at 11:41 PMQuoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2023 Financial Resultstechnews.tmcnet.com - August 3 at 8:40 AMWhat to know about Manitowoc's first Narcan vending machinenews.yahoo.com - August 2 at 10:03 AMABVC BioPharma Announces Reverse Stock Splitbenzinga.com - July 24 at 2:04 PMSavient Stock Hits New 52-Week Low (SVNT)thestreet.com - April 1 at 11:45 PM10 Most Shorted Stocks in Biotechthestreet.com - March 29 at 10:18 AM Get Savient Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SVNTQ and its competitors with MarketBeat's FREE daily newsletter. Email Address $25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time… Go here to watch the most recent trading workshop video at no charge. SVNTQ Media Mentions By Week SVNTQ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SVNTQ News Sentiment▼0.000.51▲Average News Sentiment SVNTQ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SVNTQ Articles This Week▼00▲SVNTQ Articles Average Week Get Savient Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SVNTQ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:SVNTQ) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Savient Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
